Blood vessels communicate with sensory neurons to decide whether they remain as a reservoir of stem cells or differentiate

by UPF - Universitat Pompeu Fabra

The researchers, using real-time videos, have discovered that both the neurons and the cells of blood vessels emit dynamic protrusions to be able to ‘talk’ to each other.

Read more

A quick and simple technology to improve the effectiveness of stem cells in regenerative medicine developed

by CNIO - Centro Nacional de Investigaciones Oncológicas

Stem cells have been holding great promise for regenerative medicine for years. In the last decade, several studies have shown that this type of cell, which in Spanish is called “mother cell” beca...

Read more

Asphalion participated in the nTRACK 30 MM follow up e-meeting

by Asphalion

​Last week , our colleagues Marta R​ayo and Marta Mor​ales participated in the nTRACK 30 MM follow up meeting to discuss the project progress with all the partners.

Read more

Stem cells treatment for fistulas in Crohn’s disease is about to be approved in Catalonia a

by Fundació Clínic per a la Recerca Biomèdica

Treatment with mesenchymal stem cells (MSCs), extracted from fat tissue, is a powerful tool for the cure of autoimmune diseases such as Crohn’s disease.

Read more

Therapeutic use for stem cells in the dental pulp?

by Achucarro Basque Center for Neuroscience

A collaboration research between Achucarro and the UPV/EHU discovers that dental pulp stem cells are able to integrate and generate brain neovasculogenesis

Read more

Interview Valles Visio: Nanoligent

by Hospital de la Santa Creu i Sant Pau

In June 2017, researchers from the IIB-Sant Pau, the Institute of Biotechnology and Biomedicine at the UAB and the CIBER-BBN, created a spin-off, Nanoligent, with the goal of developing the first drug...

Read more

BigH1—the key histone for male fertility

by IRB Barcelona - Instituto de Investigación Biomédica

Researchers at IRB Barcelona unravel the role of the histone BigH1 in the development of male sex cells from stem cells. The study, which was performed in Drosophila melanogaster, paves the way to a ...

Read more

A genome-editing strategy to study cancer stem cells in human tumours

by IRB Barcelona - Instituto de Investigación Biomédica

In EMBO Molecular Medicine, IRB Barcelona scientists report a technique based on a combination of CRISPR/Cas9 genome editing and patient-derived tumour organoids that allows the study of cell heteroge...

Read more

Takeda and TiGenix report new data highlighting maintenance of long-term remission of complex perianal Fistulas in Crohn’s disease patients with Cx601

by TIGENIX SAU

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq: TIG) (“TiGenix”) today announced new data from the Phase 3 ADMIRE-CD clinical trial, ...

Read more

Dr. Matilde Lleonart publishes a article about the resistance to the treatment of some kind of tumors

by Vall d’Hebron

In this article, the investigators propose different mechanisms responsible of the resistance to therapy. Cancer stem cells are resistant because are protected at a molecular level by potent detoxific...

Read more

Dr. Lleonart receives one of the grants from the Spanish Association against Cancer

by Vall d’Hebron

Specifically, the main objective of the project is to identify molecular pathways which inhibition reverse the acquisition of resistance to chemotherapeutic agents in patients with head and neck tumou...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

La fábrica digital, el futuro de la in...

by IQS Institut Químic de Sarrià

La necesidad de digitalización del sector industrial es ya una realid...

Photos Stream